Portage resumes enrollment in final cohort of dose escalation for ADPORT-601
Portage Biotech (PRTG) announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a ...
Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT ...
Combining PORT-6 and PORT-7 for a More Comprehensive Immunotherapy Approach ...